Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease

NCT05675436 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT05675436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05675436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Active, not recruiting
Start date
May 9, 2024
Completion date
October 27, 2027
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hbsc, hbss, sickle beta thalassemia, sickle beta zero thalassemia, sickle cell anemia, sickle cell pain, sickle cell syndrome variant, sickle cell thalassemia